Here, we performed comprehensive phenotypic and functional analyses on the blood samples collected from AML patients and discovered that CD26<sup>low</sup>PD-1<sup>+</sup> CD8 T cells were associated with AML progression. The gene discussed is CD8A; the disease is acute myeloid leukemia.